10Chien KR,Grace AA,Minamisawa S,et al. Japanese Circulation Journal . 1997
同被引文献35
1Lonn Em,Yusu fs,Jba P,et al.Emergingrole of angiotensin-converting enzyme inhibitors in Cardiac and Vascular proection.Circulation,1994,90:2056-2069.
2Williams M L.Targeted -? adrenergic.receptor kinase (? ARK1) inhibition by gene etransfer in failiing.human hearts.Circulation 2004,109:1590-1593.
3Maack C,Elter T,Nickenig G,et al.Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.Am Coll Cardiol,2001,38:939-946.
4Patrick M,Carmen E,Mirko V,et al.Hope for a broken heart? Trends in Biotechenology,2004,22:487-489.
5Xiao RP,Zhu W,Zheng M,et al.Subtype-specific beta-adrenoceptor signaling,Path ways in the heart and their potential clinical implications.Eur Heart J,2004,25:358-365.
6Poole-wilsion.Comparision of carvediol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvediol Or Metprolol Europen Trial (COMET):radiomised.controlled.Trial.Lancent,2003,362:7-13.
7WeberkT,sun Y,Wodi LA,et al.Toward a broader understanding of aldosterone in congestive heart failure.J Renin Angiotensin Aldosterone Syst,2003,4:155-163.
8Pitt B,Remme W,Zannad F,et al.Eplenrenore,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction.N Engl J Med,2003,348:1309-1321.
9Levy DG,Rocha R,Funder JW.Distinguishing the antihypertensive and electrolyte effects of eplerenone.J Clin Endocrinol Metab,2004,89:2736-2740.
10Weinberger MH.Eplerenone:a new selective aldosterone receptor antagonist.Drugs Today(Barc),2004,40:481-485.
